Outcome of Board Meeting
With respect to captioned subject, we would like to inform you that the Board of Directors of the Company at its Meeting held today i.e., November 09, 2017 , inter alia has approved the Scheme of Amalgamation of M/s. Gufic Lifesciences Private Limited with the Company. Board Meeting On November 09, 2017
Pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 09, 2017, inter alia, to consider and approve the draft scheme of amalgamation, valuation report determining the share exchange ratio and the fairness opinion for the amalgamation... Updates
Receipt of Approval for Reclassification of shares under Regulation 31A of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from the Practicing Company Secretary for the half year ended 30th September, 2017. Clarification
With reference to increase in Volume, Gufic Biosciences Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Gufic Biosciences Ltd
The Exchange has sought clarification from Gufic Biosciences Ltd on October 25, 2017, with reference to increase in Volume.The reply is awaited. Compliance Certificate Under Regulation 7(3) Of SEBI(Listing Obligation & Disclosure Requirements) Regulations, 2015 For Half Year Ended September 30, 2017
Compliance Certificate for the half year ended September 30, 2017 pursuant to Regulation 7(3) of SEBI(LODR) Regulations, 2017 Statement Of Investor Complaints For The Quarter Ended September 30, 2017
Enclosed is the statement of Investor Complaints for the Quarter ended September 30, 2017 Financial Results For Quarter Ended June 30, 2017
Enclosed is the Unaudited Financial REsults Updates
Approval of Members for Re-classification of Promoters at the 33rd Annual General Meeting of the Company